Loading clinical trials...
Loading clinical trials...
T2D is a major public health problem and is currently the 7th leading cause of death in the US. Despite a range of efficacious treatments, less than 50% of patients achieve a glycemic target of A1c \<...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ohio State University
Collaborators
NCT07321678 · T2DM (Type 2 Diabetes Mellitus)
NCT07314684 · T2DM (Type 2 Diabetes Mellitus)
NCT06293417 · T2DM (Type 2 Diabetes Mellitus), Dyslipidemias
NCT07172997 · MASLD, T2DM (Type 2 Diabetes Mellitus), and more
NCT06733805 · Clinical Audit, Quality Improvement, and more
The Ohio State University Wexner Medical Center
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions